Overview
- 25 inspections across 25 sites are on record.
- 36 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-22.
At a glance
Inspections
25
Sites
25
Observations
36
Career since
Jan 2020
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Ibex Preclinical Research, Inc. | 22 May 2026 | Medical Devices & Rad Health | View 483 → |
| Shanghai InnoStar Bio-tech Co., Ltd. | 20 Mar 2026 | Human Drugs | On file |
| Suzhou Frontage New Drug Development Co., Ltd. | 13 Mar 2026 | Human Drugs | On file |
| Bristol-Myers Squibb Company | 12 Dec 2025 | Human Drugs | |
| Immunologix Laboratories | 12 Sep 2025 | Human Drugs | View 483 → |
Sites inspected
Ibex Preclinical Research, Inc.Logan, United States1 insp.
Shanghai InnoStar Bio-tech Co., Ltd.Pu Dongxin District, China1 insp.
Suzhou Frontage New Drug Development Co., Ltd.Suzhou, China1 insp.
Bristol-Myers Squibb CompanyNew Brunswick, United States1 insp.
Immunologix LaboratoriesTampa, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Kathryn Suttling5 shared
Courtney R Bratina2 shared
Yuanyuan Li2 shared
Zhou Chen2 shared
Betsy C Galliher2 shared
Matthew C Watson2 shared
Stephanie C Mangigian2 shared
Jeanne J Thai2 shared
Jonathan R Campos2 shared
Audrey J Yarbrough1 shared
Full investigator report
Get the verbatim findings behind Erin M Mcdowell's 36 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site